VYNE icon

VYNE Therapeutics

54 hedge funds and large institutions have $12.5M invested in VYNE Therapeutics in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 17 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

less ownership

Funds ownership:

less funds holding

Funds holding:

less capital invested

Capital invested by funds: $ → $

47% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 19

53% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 17

Holders
54
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$95K
Puts
$26K
Net Calls
Net Calls Change

Top Buyers

1 +$1.48M
2 +$169K
3 +$128K
4
Goldman Sachs
Goldman Sachs
New York
+$75.1K
5
VF
Virtu Financial
New York
+$68.4K

Top Sellers

1 -$1.81M
2 -$994K
3 -$347K
4
CM
CM Management
Florida
-$200K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$194K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$2.6M
2
$2.29M
3
$2.22M
4
$1.03M
5
$923K
6
$555K
7
$479K
8
$440K
9
$222K
10
$179K
11
$169K
12
$145K
13
$138K
14
$131K
15
$125K
16
$118K
17
$101K
18
$91K
19
$67K
20
$64K
21
$48K
22
$46K
23
$34K
24
$33K
25
$31K